Thiazole, a versatile five-membered heterocyclic scaffold containing sulfur and nitrogen atoms, has emerged as a pivotal pharmacophore in medicinal chemistry due to its unique chemical properties and broad spectrum of biological activities. Recent studies have revealed that thiazole derivatives possess potent antimicrobial, anticancer, anti-inflammatory, and antioxidant properties, making them promising candidates for therapeutic development. The unique electronic structure of the thiazole ring facilitates strong interactions with various biological targets, enabling modulation of key enzymes and signaling pathways involved in disease progression. Notably, thiazole-based pharmacological agents have shown promise in overcoming drug resistance and improving pharmacokinetic profiles, positioning them as valuable leads in the development of novel therapeutics. This review consolidates current knowledge on thiazole derivatives, emphasizing their diverse biological activities, pharmacological applications, and mechanisms of action, highlighting their potential as multi-target agents against resistant microbial strains and complex diseases.
Thorat et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: